CFN Media Exclusive Interview with NanoSphere Health Sciences President and COO Mr. David Sutton

As research into cannabis has grown, the demand for new and innovative delivery methods has exploded. NanoSphere Health Sciences (NSHS.CN) (CSE:NSHS) (CNSX: NSHS) is disrupting the space through its innovative delivery systems, which include transdermal, intraoral, and intranasal applications. The Evolve NanoSerum won the 2017 Dope Cup Award for Best Transdermal and the company recently signed an agreement to license their cannabis technology to the state of California.

CFN sat down with NanoSphere Health Sciences COO David Sutton at the recent Seed to Sale show in Denver Colorado.

Samuel TheilComment